Abstract
Intravenous iron therapy for patients with heart failure: expanding body of evidence.
Highlights
Anaemia represents a common co-morbidity in patients with heart failure (HF)
As ferritin represents an acute phase mediator, these cut-off levels cannot be used in HF, a disease marked by chronic inflammation
In their post hoc analysis of FAIR-HF, Onoko et al confirmed that calculated plasma volume status predicts death and hospitalizations in a chronic HF cohort
Read more 
Summary
Christopher Adlbrecht
Anaemia (haemoglobin
Definition and core evidence for intravenous iron in heart failure
Hypersensitivity reactions of intravenous iron
Findings
Conclusions
Sign-in/Register to view highlights & summary Full Text Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
